A detailed history of Oppenheimer Asset Management Inc. transactions in Argenx Se stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 3,220 shares of ARGX stock, worth $2.02 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,220
Previous 3,255 1.08%
Holding current value
$2.02 Million
Previous $1.4 Million 24.8%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$434.22 - $551.9 $15,197 - $19,316
-35 Reduced 1.08%
3,220 $1.75 Million
Q2 2024

Aug 08, 2024

BUY
$356.01 - $451.55 $120,687 - $153,075
339 Added 11.63%
3,255 $1.4 Million
Q1 2024

May 06, 2024

BUY
$356.95 - $413.29 $54,256 - $62,820
152 Added 5.5%
2,916 $1.15 Million
Q4 2023

Feb 13, 2024

BUY
$338.91 - $506.01 $36,602 - $54,649
108 Added 4.07%
2,764 $1.05 Million
Q3 2023

Nov 07, 2023

BUY
$369.35 - $548.43 $122,254 - $181,530
331 Added 14.24%
2,656 $1.31 Million
Q2 2023

Aug 02, 2023

BUY
$360.14 - $422.58 $397,594 - $466,528
1,104 Added 90.42%
2,325 $906,000
Q1 2023

May 10, 2023

SELL
$334.23 - $403.65 $42,447 - $51,263
-127 Reduced 9.42%
1,221 $454,000
Q4 2022

Feb 06, 2023

SELL
$342.17 - $402.31 $17,108 - $20,115
-50 Reduced 3.58%
1,348 $510,000
Q3 2022

Nov 14, 2022

SELL
$343.2 - $395.75 $117,374 - $135,346
-342 Reduced 19.66%
1,398 $494,000
Q2 2022

Aug 08, 2022

SELL
$269.58 - $378.88 $7,548 - $10,608
-28 Reduced 1.58%
1,740 $659,000
Q1 2022

May 12, 2022

BUY
$254.45 - $351.06 $153,433 - $211,689
603 Added 51.76%
1,768 $558,000
Q4 2021

Feb 02, 2022

BUY
$272.01 - $353.03 $9,248 - $12,003
34 Added 3.01%
1,165 $408,000
Q3 2021

Nov 12, 2021

SELL
$295.0 - $350.58 $11,505 - $13,672
-39 Reduced 3.33%
1,131 $341,000
Q2 2021

Aug 03, 2021

SELL
$257.11 - $319.92 $2,571 - $3,199
-10 Reduced 0.85%
1,170 $352,000
Q1 2021

May 17, 2021

BUY
$268.3 - $380.31 $1,341 - $1,901
5 Added 0.43%
1,180 $325,000
Q4 2020

Feb 11, 2021

SELL
$248.13 - $308.36 $43,670 - $54,271
-176 Reduced 13.03%
1,175 $345,000
Q3 2020

Nov 13, 2020

SELL
$215.51 - $272.51 $6,465 - $8,175
-30 Reduced 2.17%
1,351 $355,000
Q2 2020

Aug 11, 2020

BUY
$127.44 - $232.72 $9,940 - $18,152
78 Added 5.99%
1,381 $311,000
Q1 2020

May 08, 2020

BUY
$108.83 - $165.23 $34,281 - $52,047
315 Added 31.88%
1,303 $172,000
Q4 2019

Feb 07, 2020

BUY
$106.59 - $164.21 $105,310 - $162,239
988 New
988 $159,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.